BackXenon Pharmaceuticals Overview

Xenon Pharmaceuticals Intangible Assets

Latest intangible assets for XENE: $0.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00

Peer trimmed avg / median

Loading

Xenon Pharmaceuticals Intangible Assets History

Loading

Xenon Pharmaceuticals vs. peers: Intangible Assets Comparison

Loading

Xenon Pharmaceuticals Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Xenon Pharmaceuticals (XENE) FAQ

As of the most recent data (June 2026), XENE shows a intangible assets of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XENE's intangible assets is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Xenon Pharmaceuticals is outperforming or lagging.

Tracking XENE's intangible assets over time shows whether Xenon Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Xenon Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $0) with ownership activity and broader fundamentals.

Xenon Pharmaceuticals's intangible assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.